135 related articles for article (PubMed ID: 7959906)
21. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1 beta.
Reddy S; Salari-Lak N; Sandler S
Endocrinology; 1995 May; 136(5):1907-12. PubMed ID: 7720637
[TBL] [Abstract][Full Text] [Related]
23. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
Strandell E; Sandler S
J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
[TBL] [Abstract][Full Text] [Related]
24. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F
Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
Sandler S; Andersson A; Hellerström C
Endocrinology; 1987 Oct; 121(4):1424-31. PubMed ID: 3308437
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
27. Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells.
Eizirik DL; Tracey DE; Bendtzen K; Sandler S
Autoimmunity; 1992; 12(2):127-33. PubMed ID: 1535517
[TBL] [Abstract][Full Text] [Related]
28. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.
Mathieu C; Waer M; Casteels K; Laureys J; Bouillon R
Endocrinology; 1995 Mar; 136(3):866-72. PubMed ID: 7867594
[TBL] [Abstract][Full Text] [Related]
29. Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets.
Vinci C; Caltabiano V; Santoro AM; Rabuazzo AM; Buscema M; Purrello R; Rizzarelli E; Vigneri R; Purrello F
Diabetologia; 1995 Jan; 38(1):39-45. PubMed ID: 7744228
[TBL] [Abstract][Full Text] [Related]
30. Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat.
Bourlon PM; Faure-Dussert A; Billaudel B
Br J Pharmacol; 1997 Jun; 121(4):751-8. PubMed ID: 9208144
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation.
Sjöholm A
FEBS Lett; 1991 Sep; 289(2):249-52. PubMed ID: 1655527
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1.
Sandler S; Welsh N
Biochem Biophys Res Commun; 1993 Sep; 195(2):859-65. PubMed ID: 8373422
[TBL] [Abstract][Full Text] [Related]
33. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.
Eizirik DL; Strandell E; Bendtzen K; Sandler S
Diabetes; 1988 Jul; 37(7):916-9. PubMed ID: 3290009
[TBL] [Abstract][Full Text] [Related]
34. Effect of 1,25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats.
Billaudel BJ; Faure AG; Sutter BC
Am J Physiol; 1990 Apr; 258(4 Pt 1):E643-8. PubMed ID: 2185647
[TBL] [Abstract][Full Text] [Related]
35. Is 1,25-dihydroxyvitamin D3 the specific vitamin D3 metabolite active on insulin release and calcium handling by islets from vitamin D3-deprived rats?
Faure A; Sutter BC; Billaudel B
Diabete Metab; 1991; 17(2):271-8. PubMed ID: 1650716
[TBL] [Abstract][Full Text] [Related]
36. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
[TBL] [Abstract][Full Text] [Related]
37. Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium.
Borg LA; Eizirik DL
Immunol Lett; 1990 Dec; 26(3):253-8. PubMed ID: 2086454
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures.
Rabinovitch A; Pukel C; Baquerizo H
Endocrinology; 1988 Jun; 122(6):2393-8. PubMed ID: 2453340
[TBL] [Abstract][Full Text] [Related]
39. Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap.
Rydgren T; Bengtsson D; Sandler S
Diabetes; 2006 May; 55(5):1407-12. PubMed ID: 16644698
[TBL] [Abstract][Full Text] [Related]
40. Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function.
Ishida H; Seino Y; Seino S; Tsuda K; Takemura J; Nishi S; Ishizuka S; Imura H
Life Sci; 1983 Oct; 33(18):1779-86. PubMed ID: 6139721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
